| Application of nanoparticle technologies in the combat against anti-microbial resistance M Kumar, A Curtis, C Hoskins Pharmaceutics 10 (1), 11, 2018 | 125 | 2018 |
| The use of nanotechnology in cardiovascular disease M Chandarana, A Curtis, C Hoskins Applied Nanoscience 8, 1607-1619, 2018 | 98 | 2018 |
| Structure correction and synthesis of the naturally occurring benzothiazinone BMY 40662 TR Kelly, MH Kim, ADM Curtis The Journal of Organic Chemistry 58 (21), 5855-5857, 1993 | 96 | 1993 |
| Comprehensive heterocyclic chemistry III DL Comins, S O’Connor, RS Al-awar, AR Katritzky, CA Ramsden, ... Alan, RK, 41, 2008 | 79* | 2008 |
| Synthesis and characterization of TPGS–gemcitabine prodrug micelles for pancreatic cancer therapy V Khare, WA Sakarchi, PN Gupta, ADM Curtis, C Hoskins RSC advances 6 (65), 60126-60137, 2016 | 66 | 2016 |
| Preclinical evaluation of statins as a treatment for ovarian cancer E Robinson, M Nandi, LL Wilkinson, DM Arrowsmith, ADM Curtis, ... Gynecologic oncology 129 (2), 417-424, 2013 | 59 | 2013 |
| The use of iron oxide nanoparticles for pancreatic cancer therapy M Malekigorji, ADM Curtis, C Hoskins Journal of Nanomedicine Research 1 (1), 2014 | 58 | 2014 |
| Nanotechnologies in pancreatic cancer therapy A Manzur, A Oluwasanmi, D Moss, A Curtis, C Hoskins Pharmaceutics 9 (4), 39, 2017 | 53 | 2017 |
| Stimuli responsive polymeric systems for cancer therapy A Alsuraifi, A Curtis, DA Lamprou, C Hoskins Pharmaceutics 10 (3), 136, 2018 | 51 | 2018 |
| 1, 2, 4‐Triazoles ADM Curtis ChemInform 36 (11), no-no, 2005 | 47 | 2005 |
| Novel calix [4] resorcinarene glycosides ADM Curtis Tetrahedron letters 38 (24), 4295-4296, 1997 | 41 | 1997 |
| Diels Alder-mediated release of gemcitabine from hybrid nanoparticles for enhanced pancreatic cancer therapy A Oluwasanmi, W Al-Shakarchi, A Manzur, MH Aldebasi, RS Elsini, ... Journal of Controlled Release 266, 355-364, 2017 | 40 | 2017 |
| Simple calix [n] arenes and calix [4] resorcinarenes as drug solubilizing agents C Hoskins, ADM Curtis Journal of Nanomedicine Research 2 (3), 2015 | 35 | 2015 |
| Thermally triggered theranostics for pancreatic cancer therapy M Malekigorji, M Alfahad, PKT Lin, S Jones, A Curtis, C Hoskins Nanoscale 9 (34), 12735-12745, 2017 | 30 | 2017 |
| Asymmetric Diels–Alder reactions. Part 6. Regio-and stereo-selective cycloadditions of 5-(2′, 3′, 4′, 6′-tetra-O-acetyl-β-D-glucopyranosyloxy)-1, 4-naphthoquinone DM Anthony Journal of the Chemical Society, Perkin Transactions 1, 1981-1991, 1992 | 30 | 1992 |
| Combined effect of anticancer agents and cytochrome C decorated hybrid nanoparticles for liver cancer therapy W Al-Shakarchi, A Alsuraifi, M Abed, M Abdullah, A Richardson, A Curtis, ... Pharmaceutics 10 (2), 48, 2018 | 29 | 2018 |
| Product Class 14: 1, 2, 4-Triazoles ADM Curtis Science of Synthesis 13, 603-639, 2004 | 28 | 2004 |
| Interaction of a water soluble fullerene derivative with reactive oxygen species and model enzymatic systems S Foley, ADM Curtis, A Hirsch, M Brettreich, A Pelegrin, P Seta, ... Fullerenes, Nanotubes and Carbon Nanostructures 10 (1), 49-67, 2002 | 26 | 2002 |
| Stereoselective aldol reactions of β-boronate carbonyl derivatives. ADM Curtis, A Whiting Tetrahedron letters 32 (11), 1507-1510, 1991 | 25 | 1991 |
| Investigation into drug solubilisation potential of sulfonated calix [4] resorcinarenes C Hoskins, A Papachristou, TMH Ho, J Hine, ADM Curtis Journal of Nanomedicine and Nanotechnology 7 (2), 370, 2016 | 21 | 2016 |
